Sequans Communications Announces Fourth Quarter and Full Year 2022 Financial Results
Sequans Communications S.A. (NYSE: SQNS) reported its fourth quarter and full year financial results for 2022, achieving $60.6 million in annual revenue, a 19% increase year-over-year. Q4 revenue was $15.9 million, consistent with expectations. Gross margin improved to 75.3% in Q4, aiding a substantial reduction in annual operating loss from $18.3 million in 2021 to $3.8 million in 2022. The company successfully executed a multi-year 5G licensing deal valued at over $50 million and aims to accelerate product shipments and revenue growth in the latter half of 2023. Approximately half of the $700 million revenue pipeline is backed by significant design wins.
- Achieved $60.6 million annual revenue in 2022, a 19% increase from 2021.
- Gross margin improved to 75.3% in Q4 2022.
- Reduced annual operating loss significantly to $3.8 million in 2022 from $18.3 million in 2021.
- Executed a strategic 5G licensing deal valued at over $50 million.
- Net loss of $5.0 million in Q4 2022, worsening from $2.9 million in Q3 2022.
- Operating profit turned to a loss of $1.0 million in Q4 2022.
Fourth Quarter 2022 and Full Year Summary Results Table:
(in US$ millions, except share and per share data) | Q4 2022 | Q3 2022 | Q4 2021 | Full year | Full year |
Revenue | |||||
Gross profit | 12.0 | 12.8 | 7.9 | 42.9 | 27.2 |
Gross margin (%) | 75.3 % | 77.6 % | 57.1 % | 70.8 % | 53.4 % |
Operating profit (loss) | (1.0) | 1.2 | (4.0) | (3.8) | (18.3) |
Net Profit (Loss) | (5.0) | (2.9) | (7.7) | (9.0) | (20.3) |
Diluted earnings (loss) per ADS | ( | ( | ( | ( | ( |
Non-IFRS diluted earnings (loss) per ADS * | ( | ( | ( | ( | |
Weighted average number of diluted ADS (IFRS) | 47,951,407 | 47,802,526 | 37,497,367 | 46,146,776 | 36,672,946 |
Weighted average number of diluted ADS (Non-IFRS) | 47,951,407 | 52,620,229 | 37,497,367 | 46,146,776 | 36,672,946 |
* See Use of Non-IFRS/non-GAAP Financial Measures disclosure on page 3. IFRS Net Profit (Loss) includes significant non-cash interest | |||||
"Notable accomplishments in 2022 set the stage for sustainable long-term growth and market share gains in the largest IoT markets," said
"We expect product shipments to accelerate and revenue growth to resume in the second half of 2023 with the scheduled launch of key design wins into production," continued
Q1 2023 Outlook
The following statement is based on management's current assumptions and expectations. This statement is forward-looking and actual results may differ materially.
Taking into consideration the impact of excess inventory primarily at one key customer, the delay of design win project launches, and the historically seasonally lower activity in the first quarter, management is targeting revenues of around
Fourth Quarter 2022 Highlights:
Revenue: Revenue was
Gross margin: Gross margin was
Operating profit / loss: Operating loss was
Net profit / loss: Net loss was
Non-IFRS Net profit / loss and diluted profit / loss per ADS: Excluding the non-cash stock-based compensation, the non-cash impact of the fair-value, the amendment and effective interest adjustments related to the convertible debt with embedded derivatives and other financings, non-IFRS net loss was
Cash: Cash and cash equivalents and short-term deposits at
Conference Call and Webcast
Forward Looking Statements
This press release contains projections and other forward-looking statements regarding future events and our future financial performance. All statements other than present and historical facts and conditions contained in this release, including any statements regarding future results of operations and financial positions, business strategy and plans, expectations for future product sales, potential for future strategic licensing deals or other strategic transactions, the impact of the Covid-19 on our supply chain and on customer demand, the impact of component shortages and manufacturing capacity, our ability to convert our pipeline to revenue and our objectives for future operations, are forward-looking statements (within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended). These statements are only predictions and reflect our current beliefs and expectations with respect to future events and are based on assumptions and subject to risk and uncertainties and subject to change at any time. We undertake no obligation to update the information made in this release in the event facts or circumstances subsequently change after the date of this press release. We operate in a very competitive and rapidly changing environment. New risks emerge from time to time. Given these risks and uncertainties, you should not rely on or place undue reliance on these forward-looking statements. Actual events or results may differ materially from those contained in the projections or forward-looking statements. In addition to the risk factors contained in our Form 20-F for the fiscal year ended
Use of Non-IFRS/non-GAAP Financial Measures
To supplement our unaudited consolidated financial statements prepared in accordance with IFRS, we disclose certain non-IFRS, or non-GAAP, financial measures. These measures exclude the non-cash stock-based compensation and the non-cash impacts of convertible debt amendments, conversions and repayments, effective interest adjustments related to the convertible debt with embedded derivatives and other financings; and deferred tax benefit or expense related to the convertible debt and other financings. We believe that these measures can be useful to facilitate comparisons among different companies. These non-GAAP measures have limitations in that the non-GAAP measures we use may not be directly comparable to those reported by other companies. We seek to compensate for this limitation by providing a reconciliation of the non-GAAP financial measures to the most directly comparable IFRS measures in the table attached to this press release.
About
Visit
Media Relations:
Investor Relations:
Condensed financial tables follow
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS | ||||||||
Three months ended | ||||||||
(in thousands of US$, except share and per share |
| September |
| |||||
Revenue : | ||||||||
Product revenue | $ 4,990 | $ 4,385 | $ 6,924 | |||||
License and services revenue | 10,921 | 12,143 | 6,886 | |||||
Total revenue | 15,911 | 16,528 | 13,810 | |||||
Cost of revenue | 3,935 | 3,708 | 5,922 | |||||
Gross profit | 11,976 | 12,820 | 7,888 | |||||
Operating expenses : | ||||||||
Research and development | 7,361 | 6,924 | 6,678 | |||||
Sales and marketing | 2,561 | 2,438 | 2,342 | |||||
General and administrative | 3,040 | 2,243 | 2,897 | |||||
Total operating expenses | 12,962 | 11,605 | 11,917 | |||||
Operating profit (loss) | (986) | 1,215 | (4,029) | |||||
Financial income (expense): | ||||||||
Interest income (expense), net | (2,543) | (2,784) | (2,475) | |||||
Change in fair value of convertible debt derivative | 1,011 | (1,193) | (1,176) | |||||
Impact of debt amendment and reimbursement | — | 476 | — | |||||
Foreign exchange gain (loss) | (1,536) | 1,030 | 135 | |||||
Profit (Loss) before income taxes | (4,054) | (1,256) | (7,545) | |||||
Income tax expense | 907 | 1,617 | 173 | |||||
Profit (Loss) | $ (4,961) | $ (2,873) | $ (7,718) | |||||
Attributable to : | ||||||||
Shareholders of the parent | (4,961) | (2,873) | (7,718) | |||||
Minority interests | — | — | — | |||||
Basic loss per ADS | ( | ( | ( | |||||
Diluted loss per ADS | ( | ( | ( | |||||
Weighted average number of ADS used for computing: | ||||||||
— Basic | 47,951,407 | 47,802,526 | 37,497,367 | |||||
— Diluted | 47,951,407 | 47,802,526 | 37,497,367 |
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS | |||||
Twelve months ended | |||||
(in thousands of US$, except share and per share amounts) | 2022 | 2021 | |||
Revenue : | |||||
Product revenue | $ 22,974 | $ 30,410 | |||
License and services revenue | 37,577 | 20,469 | |||
Total revenue | 60,551 | 50,879 | |||
Cost of revenue | 17,671 | 23,690 | |||
Gross profit | 42,880 | 27,189 | |||
Operating expenses : | |||||
Research and development | 26,610 | 26,414 | |||
Sales and marketing | 10,027 | 9,049 | |||
General and administrative | 10,082 | 10,045 | |||
Total operating expenses | 46,719 | 45,508 | |||
Operating profit (loss) | (3,839) | (18,319) | |||
Financial income (expense): | |||||
Interest income (expense), net | (10,857) | (11,282) | |||
Change in fair value of convertible debt derivative | 6,878 | 3,848 | |||
Impact of debt amendment and reimbursement | 476 | 5,177 | |||
Foreign exchange gain (loss) | 1,082 | 938 | |||
Profit (Loss) before income taxes | (6,260) | (19,638) | |||
Income tax expense | 2,748 | 625 | |||
Profit (Loss) | $ (9,008) | $ (20,263) | |||
Attributable to : | |||||
Shareholders of the parent | (9,008) | (20,263) | |||
Minority interests | — | — | |||
Basic loss per ADS | ( | ( | |||
Diluted loss per ADS | ( | ( | |||
Weighted average number of ADS used for computing: | |||||
— Basic | 46,146,776 | 36,672,946 | |||
— Diluted | 46,146,776 | 36,672,946 |
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF FINANCIAL POSITION | ||||
At | At | |||
(in thousands of US$) | 2022 | 2021 | ||
ASSETS | ||||
Non-current assets | ||||
Property, plant and equipment | $ 8,489 | $ 8,010 | ||
Intangible assets | 48,705 | 37,984 | ||
Deposits and other receivables | 783 | 2,311 | ||
Other non-current financial assets | 337 | 357 | ||
Total non-current assets | 58,314 | 48,662 | ||
Current assets | ||||
Inventories | 9,387 | 6,433 | ||
Trade receivables | 8,494 | 13,622 | ||
Contract assets | 176 | 789 | ||
Prepaid expenses | 1,399 | 2,108 | ||
Other receivables | 5,799 | 7,252 | ||
Research tax credit receivable | 4,515 | 5,863 | ||
Short-term deposits | 5,000 | — | ||
Cash and cash equivalents | 5,671 | 4,835 | ||
Total current assets | 40,441 | 40,902 | ||
Total assets | $ 98,755 | $ 89,564 | ||
EQUITY AND LIABILITIES | ||||
Equity | ||||
Issued capital, | $ 2,306 | $ 3,687 | ||
Share premium | 2,418 | 298,389 | ||
Other capital reserves | 62,870 | 57,198 | ||
Accumulated deficit | (65,099) | (383,554) | ||
Other components of equity | (391) | (26) | ||
Total equity | 2,104 | (24,306) | ||
Non-current liabilities | ||||
Government grant advances, loans and other liabilities | 6,235 | 9,354 | ||
Convertible debt | 43,455 | 36,373 | ||
Convertible debt embedded derivative | 3,203 | 10,081 | ||
Lease liabilities | 2,278 | 3,373 | ||
Trade payables | 1,788 | 964 | ||
Provisions | 2,196 | 2,137 | ||
Deferred tax liabilities | 258 | 138 | ||
Contract liabilities | 404 | 2,706 | ||
Total non-current liabilities | 59,817 | 65,126 | ||
Current liabilities | ||||
Trade payables | 9,342 | 13,916 | ||
Interest-bearing receivables financing | 7,723 | 9,518 | ||
Lease liabilities | 1,291 | 1,247 | ||
Government grant advances and loans | 4,159 | 6,206 | ||
Contract liabilities | 5,774 | 8,677 | ||
Other current liabilities and provisions | 8,545 | 9,180 | ||
Total current liabilities | 36,834 | 48,744 | ||
Total equity and liabilities | $ 98,755 | $ 89,564 |
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOW | ||||||
Twelve months ended | ||||||
(in thousands of US$) | 2022 | 2021 | ||||
Operating activities | ||||||
Profit (Loss) before income taxes | $ (6,260) | $ (19,638) | ||||
Non-cash adjustment to reconcile income before tax to net cash from (used in) | ||||||
Depreciation and impairment of property, plant and equipment | 3,979 | 3,354 | ||||
Amortization and impairment of intangible assets | 8,033 | 7,199 | ||||
Share-based payment expense | 5,477 | 5,135 | ||||
Increase in provisions | 207 | 461 | ||||
Interest expense, net | 10,857 | 11,285 | ||||
Change in the fair value of convertible debt embedded derivative | (6,878) | (3,848) | ||||
Impact of debt reimbursement | (476) | (5,177) | ||||
Foreign exchange loss (gain) | (391) | (1,034) | ||||
Loss (Gain) on disposal of property, plant and equipment | 24 | 48 | ||||
Bad debt expense | — | 65 | ||||
Working capital adjustments | ||||||
Decrease (Increase) in trade receivables and other receivables | 6,660 | 1,366 | ||||
Decrease (increase) in inventories | (2,954) | (208) | ||||
Increase in research tax credit receivable | (1,556) | (3,682) | ||||
Increase (Decrease) in trade payables and other liabilities | (6,970) | 4,693 | ||||
Decrease in contract liabilities | (6,171) | (6,791) | ||||
Decrease in government grant advances | (2,456) | (1,387) | ||||
Income tax paid | (2,964) | (346) | ||||
Net cash flow provided by (used in) operating activities | (1,839) | (8,505) | ||||
Investing activities | ||||||
Purchase of intangible assets and property, plant and equipment | (7,169) | (9,544) | ||||
Capitalized development expenditures | (15,494) | (19,375) | ||||
Sale (Purchase) of financial assets | 1,548 | (1,694) | ||||
Decrease of short-term deposit | (5,000) | 10,900 | ||||
Interest received | 68 | 47 | ||||
Net cash flow provided by (used in) investments activities | (26,047) | (19,666) | ||||
Financing activities | ||||||
Proceeds from issue of warrants, exercise of stock options/warrants | — | 138 | ||||
Public and private equity offering proceeds, net of transaction costs paid | 30,111 | 9,852 | ||||
Proceeds (Repayment of) from interest-bearing receivables financing | 3,046 | 21 | ||||
Proceeds from convertible debt, net of transaction cost | — | 39,682 | ||||
Payment of lease liabilities | (1,205) | (1,063) | ||||
Repayment of convertible debt and accrued expenses | — | (8,750) | ||||
Repayment of government loans | (958) | (469) | ||||
Repayment of venture debt | — | (7,869) | ||||
Repayment of interest-bearing research project financing | (812) | (804) | ||||
Interest paid | (1,467) | (5,310) | ||||
Net cash flows from (used in) financing activities | 28,715 | 25,428 | ||||
Net increase (decrease) in cash and cash equivalents | 829 | (2,743) | ||||
Net foreign exchange difference | 7 | 4 | ||||
Cash and cash equivalents at | 4,835 | 7,574 | ||||
Cash and cash equivalents at end of the period | 5,671 | 4,835 |
UNAUDITED RECONCILIATION OF NON-IFRS FINANCIAL RESULTS | |||||||
(in thousands of US$, except share and per share amounts) | Three months ended | ||||||
| September |
| |||||
Net IFRS gain (loss) as reported | $ (4,961) | $ (2,873) | $ (7,718) | ||||
Add back | |||||||
Non-cash stock-based compensation expense according to IFRS 2 (1) | 1,810 | 1,133 | 1,861 | ||||
Non-cash change in the fair value of convertible debt embedded | (1,011) | 1,193 | 1,176 | ||||
Non-cash interest on convertible debt and other financing (2) | 1,404 | 1,447 | 1,219 | ||||
Non-cash impact of convertible debt amendment | — | (476) | — | ||||
Non-IFRS gain (loss) adjusted | $ (2,758) | $ 424 | $ (3,462) | ||||
IFRS basic gain (loss) per ADS as reported | ( | ( | ( | ||||
Add back | |||||||
Non-cash stock-based compensation expense according to IFRS 2 (1) | |||||||
Non-cash change in the fair value of convertible debt embedded | ( | ||||||
Non-cash interest on convertible debt and other financing (2) | |||||||
Non-cash impact of convertible debt amendment | |||||||
Non-IFRS basic gain (loss) per ADS | ( | ( | |||||
IFRS diluted gain (loss) per ADS | ( | ( | ( | ||||
Add back | |||||||
Non-cash stock-based compensation expense according to IFRS 2 (1) | |||||||
Non-cash change in the fair value of convertible debt embedded | ( | ||||||
Non-cash interest on convertible debt and other financing (2) | |||||||
Non-cash impact of convertible debt amendment | |||||||
Non-IFRS diluted gain (loss) per ADS | ( | ( | |||||
(1) Included in the IFRS loss as follows: | |||||||
Cost of product revenue | $ 45 | $ 41 | $ 14 | ||||
Research and development | 601 | 370 | 555 | ||||
Sales and marketing | 286 | 268 | 346 | ||||
General and administrative | 878 | 454 | 946 | ||||
(2) Related to the difference between contractual and effective interest rates |
UNAUDITED RECONCILIATION OF NON-IFRS FINANCIAL RESULTS | |||||
(in thousands of US$, except share and per share amounts) | Twelve months ended | ||||
2022 | 2021 | ||||
Net IFRS gain (loss) as reported | $ (9,008) | $ (20,263) | |||
Add back | |||||
Non-cash stock-based compensation expense according to IFRS 2 (1) | 5,477 | 5,135 | |||
Non-cash change in the fair value of convertible debt embedded | (6,878) | (3,848) | |||
Non-cash interest on convertible debt and other financing (2) | 5,521 | 4,684 | |||
Impact of debt reimbursement | — | (5,177) | |||
Non-cash impact of convertible debt amendment | (476) | — | |||
Non-IFRS gain (loss) adjusted | $ (5,364) | $ (19,469) | |||
IFRS basic gain (loss) per ADS as reported | ( | ( | |||
Add back | |||||
Non-cash stock-based compensation expense according to IFRS 2 (1) | |||||
Non-cash change in the fair value of convertible debt embedded | ( | ( | |||
Non-cash interest on convertible debt and other financing (2) | |||||
Impact of debt reimbursement | ( | ||||
Non-cash impact of convertible debt amendment | ( | ||||
Non-IFRS basic gain (loss) per ADS | ( | ( | |||
IFRS diluted gain (loss) per ADS | ( | ( | |||
Add back | |||||
Non-cash stock-based compensation expense according to IFRS 2 (1) | |||||
Non-cash change in the fair value of convertible debt embedded | ( | ( | |||
Non-cash interest on convertible debt and other financing (2) | |||||
Impact of debt reimbursement | ( | ||||
Non-cash impact of convertible debt amendment | ( | ||||
Non-IFRS diluted gain (loss) per ADS | ( | ( | |||
(1) Included in the IFRS loss as follows: | |||||
Cost of product revenue | $ 159 | $ 57 | |||
Research and development | 1,758 | 2,109 | |||
Sales and marketing | 1,132 | 970 | |||
General and administrative | 2,428 | 1,999 | |||
(2) Related to the difference between contractual and effective interest rates |
View original content to download multimedia:https://www.prnewswire.com/news-releases/sequans-communications-announces-fourth-quarter-and-full-year-2022-financial-results-301746144.html
SOURCE
FAQ
What were Sequans Communications' Q4 2022 earnings results?
How did Sequans' revenue perform in 2022?
What is Sequans' outlook for 2023?